🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard Burack

University of Rochester Medicine

ORCID: 0000-0002-5584-584X

Also affiliated with University of Rochester

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Papers

Driven by 15 papers — median percentile 90. Top paper: “The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes”.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

A Foundation Model for Spatial Proteomics

arXiv (Cornell University)(2025)10.48550/arxiv.2506.03373

N/A

0.292DataRank · unranked

6 citations

Yuzhou Chang, Huaying Qiu, Yao Yu Yeo, Guillaume Jaume, Yuchen Wang +55 more

Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood

Pediatric Blood & Cancer(2020)10.1002/pbc.28280

N/A

0DataRank · unranked

7 citations

Diana G. Adlowitz, Janice M. Spence, John C. H. Spence, Philip Rock, Richard Burack +1 more

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Blood(2021)10.1182/blood.2021012052

N/A

0DataRank · unranked

34 citations

Joel D. Allen, Dean Bryant, Philip Rock, Enrica Antonia Martino, Beatriz Valle‐Argos +17 more

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

The Lancet Haematology(2022)10.1016/s2352-3026(22)00033-3

N/A

0DataRank · unranked

64 citations

Melissa C. Larson, Julianne J. Lunde, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +19 more

Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia

Journal of Geriatric Oncology(2022)10.1016/j.jgo.2022.11.002

N/A

0DataRank · unranked

2 citations

Jodi Lipof, Andrea Baran, Bassil Said, Michael W. Becker, Jason H. Mendler +8 more

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009467

N/A

0DataRank · unranked

14 citations

Hongli Li, Diana G. Adlowitz, Janice M. Spence, Lisa M. Rimsza, Mazyar Shadman +7 more

FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia

Haematologica(2020)10.3324/haematol.2020.248385

N/A

0DataRank · unranked

70 citations

George B. Segel, Richard Burack, Ulrich J. Sachs, Suzanne N. Lissenberg‐Thunnissen, Gestur Vidarsson +9 more

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood(2024)10.1182/blood.2024025681

N/A

0DataRank · unranked

5 citations

Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen +18 more

Cell therapy for a rare disease- hairy cell leukemia variant

OncoImmunology(2024)10.1080/2162402x.2024.2432062

N/A

0DataRank · unranked

3 citations

Derek P. Wong, Philip Rock, Richard Burack, Akshaya Radhakrishnan, Reshmi Parameswaran +1 more

Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.05.583586

N/A

0DataRank · unranked

3 citations

Huaying Qiu, Yunhao Bai, Bokai Zhu, Yuzhou Chang, Jason Yeung +31 more

Taurine from tumour niche drives glycolysis to promote leukaemogenesis

Nature(2025)10.1038/s41586-025-09018-7

N/A

0DataRank · unranked

40 citations

Benjamin Rodems, Cameron Baker, Christina M. Kaszuba, Edgardo I. Franco, Bradley R. Smith +18 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more

29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_29

N/A

0DataRank · unranked

0 citations

Melissa C. Larson, Jonathan Day, Urshila Durani, Mazie Tsang, Dai Chihara +22 more

233 | S1608: RANDOMIZED PHASE II TRIAL COMPARING LENALIDOMIDE/OBINUTUZUMAB AND UMBRALISIB/OBINUTUZUMAB WITH CHEMOIMMUNOTHERAPY IN EARLY PROGRESSING FOLLICULAR LYMPHOMA (POD24)

Hematological Oncology(2025)10.1002/hon.70094_233

N/A

0DataRank · unranked

0 citations

H. Li, Heiko Schöder, Alex F. Herrera, Richard Burack, Brian K. Link +10 more